Concord Biotech Q1 Results

  • BSE: 543960
  • NSE: CONCORDBIO
  • ISIN: INE338H01029
  • Sector: -
BSE
2,073.341.75 (2.06%)
Volume8.86 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
2,06949.70 (2.46%)
Volume1.66 L
Updated: Mon 25 Nov, 2024 | 15:30:03
Today: 2,002.20
2,099.95
52-Wk: 1,206.00
2,658.00

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Concord Biotech Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 215.80853.17-%194.83-%
    Selling/ General/ Admin Expenses Total 31.66110.28-%28.25-%
    Depreciation/ Amortization 13.1854.03-%13.04-%
    Other Operating Expenses Total 54.56219.39-%54.02-%
    Total Operating Expense 147.70563.91-%135.72-%
    Operating Income 68.10289.26-%59.11-%
    Net Income Before Taxes 79.52322.01-%71.04-%
    Net Income 59.59240.09-%54.49-%
    Diluted Normalized EPS 5.7022.95-%5.21-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts